Hachimoji:

DNA Software CEO Dr. John SantaLucia, COO Norm Watkins and Research Scientist Holly SantaLucia participated in a recent Science paper was featured in the New York Times, CNN, NASA, Nature, and several other news outlets Read more ›

Agreement:

NEW YORK (GenomeWeb) – Fluidigm said today that it has entered into a non-exclusive distribution agreement with DNA Software to provide that firm’s CopyCount-CNV software for use with Fluidigm’s Biomark HD system.

Biomark HD is an Read more ›

Article in Nature:

DNA Software was featured in a recent article published in Nature on July 16, 2018 titled “Multiplexed identification, quantification and genotyping of infectious agents using a semiconductor biochip”. To learn more click here

Read more ›

Biology Methods & Protocols:

DNA Software Acknowledged and Referenced in Biology Methods & Protocols paper titled “An array-based melt curve analysis method for the identification and classification of closely related pathogen strains”.

Read more ›

Fall 2019 newsletter

Click here to download a pdf copy of the DNA Software Fall Newsletter

Read more ›

Large Scale Multiplex PCR Panel Design

Large Scale Multiplex PCR Panel Design with >95% Success in Hours, Not Months
John SantaLucia, Ph.D., co-founder and CEO, DNA Software
Abstract: We aim to solve the problem of multiplex PCR design by Read more ›

DNAS releases PanelPlex

Infectious disease molecular diagnostic(MDx) assays require rapid identification of pathogens and their drug resistance profiles in clinical samples use a highly multiplexed molecular approach. The market pull for such MDx assays has led to the software solution, Read more ›

DNA Software receives FastTrack award

ANN ARBOR, MICH. – At its annual meeting, Ann Arbor SPARK presented its annual FastTrack awards to 17 Washtenaw County-based companies that have demonstrated fast growth. Several of the 2016 and 2017 FastTrack award recipients Read more ›

DNAS cited in Science Advances

Early identification of pathogens is essential for limiting development of therapy-resistant pathogens and mitigating infectious disease outbreaks. Most bacterial detection schemes use target-specific probes to differentiate pathogen species, creating time and cost inefficiencies in identifying Read more ›

Increase Accuracy of Assure-CNV

A world class agricultural company compared the capabilities of Assure-CNV to their current workflow. This customer found Assure-CNV increased accuracy with 12 standard deviations versus the 8 provided by their traditional method. Their standard workflow also Read more ›